secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zivo Bioscience, Inc. (ZIVO)
CIK:        0001101026
Form:       8-K/A
Filed at:   2021-12-10T23:59:59+00:00
Accession:  0001654954-21-013009
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zivo Bioscience auditor Wolinetz, Lafazan resigns on Nov 30, 2021
-----------------------------------------------------------------

- Wolinetz, Lafazan & Company resigned as independent auditor effective Nov 30, 2021, citing personal reasons.
- No disagreements or reportable events occurred during the two most recent fiscal years or subsequent interim periods.
- Audit reports for FY2020 and FY2019 included a going-concern explanatory paragraph but were unqualified.
- Company's board is currently seeking a replacement independent registered public accounting firm.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1101026/000165495421013009/0001654954-21-013009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1101026/000165495421013009/zivo_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001654954-21-013009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer